Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
18.07
+0.77 (4.45%)
Oct 23, 2026, 3:04 PM CST
SHE:300204 Market Cap
SHE:300204 has a market cap or net worth of 9.78 billion as of October 22, 2026. It is the 8,353rd most valuable company in the world and the 1,671st biggest in China. Its market cap has decreased by 46.71% in one year.
Market Cap
9.78B
Enterprise Value
9.80B
Revenue
187.53M
Global Rank
Country Rank
#1,671 China
PE Ratio
n/a
ChartMarket Cap Chart
Since April 15, 2011, SHE:300204's market cap has increased from 3.33B to 9.78B, an increase of 194.00%. That is a compound annual growth rate of 7.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 9.78B | -25.06% |
| Dec 31, 2025 | 13.05B | 268.69% |
| Dec 31, 2024 | 3.54B | -27.07% |
| Dec 29, 2023 | 4.85B | -24.38% |
| Dec 30, 2022 | 6.42B | -22.12% |
| Dec 31, 2021 | 8.24B | 94.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Medicilon | 11.03B |
| Chengdu Olymvax Biopharmaceuticals | 10.96B |
| Tibet Cheezheng Tibetan Medicine | 10.91B |
| Inner Mongolia Furui Medical Science | 10.48B |
| Chengzhi | 9.87B |
| Mabwell (Shanghai) Bioscience | 9.85B |
| Pacific Shuanglin Bio-pharmacy | 9.12B |
| Novoprotein Scientific | 9.06B |